Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study to Evaluate the Efficacy and Safety of GNS-212-E in Bowel Preparation for Colonoscopy
Sponsor: Gunkang Pharmaceuticals, Inc
Summary
This is a prospective, randomized, single-blind, parallel, active-controlled, and multi-center Phase III clinical trial.
Official title: A Prospective, Randomized, Parallel, Multi-center, Active Controlled, Single Blind (Assessor), Phase 3 Clinical Trial in Bowel Preparation for Colonoscopy
Key Details
Gender
All
Age Range
19 Years - 79 Years
Study Type
INTERVENTIONAL
Enrollment
318
Start Date
2024-03-11
Completion Date
2024-10-16
Last Updated
2026-11-04
Healthy Volunteers
No
Conditions
Interventions
GNS-212-E1
Subjects who are randomized into this group will take GNS-212-E1 from the evening before colonoscopy to the morning of colonoscopy.
GNS-212-E2
Subjects who are randomized into this group will take GNS-212-E2 from the evening before colonoscopy to the morning of colonoscopy.
GNS-212-ER
Subjects who are randomized into this group will take active control drug (PEG3350) from the evening before colonoscopy to the morning of colonoscopy.
Locations (4)
Seoul National University Bundang Hospital
Gyeonggi-do, South Korea
Asan Medical Center.
Seoul, South Korea
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea